DAPAGLIFLOZIN USE IN HEART FAILURE WITH REDUCED EJECTION FRACTION PATIENTS: A SINGLE CENTRE COMPARISON BETWEEN REAL-LIFE AND DAPA-HF DATA

被引：0
|
作者：
Capovilla, Teresa Maria [1 ,2 ]
Mapelli, Massimo [3 ,4 ]
Mattavelli, Irene [3 ]
Salvioni, Elisabetta [3 ]
Marongiu, Alessandro [3 ,4 ]
Maranzano, Gaspare [3 ,4 ]
Vignati, Carlo [3 ]
Palermo, Pietro [3 ]
Sinagra, Gianfranco [1 ,2 ]
Agostoni, Piergiuseppe [3 ,4 ]
机构：
[1] Asugi, Cardiothoracovasc Dept, Trieste, Italy
[2] Univ Hosp Trieste, Trieste, Italy
[3] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[4] Univ Milan, Dept Cardiovasc Sci & Community Hlth, Milan, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷
关键词：
D O I：
10.1093/eurheartjsupp/suac121.466
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
356
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER
    Jhund, Pardeep S.
    Kondo, Toru
    Butt, Jawad H.
    Docherty, Kieran F.
    Claggett, Brian L.
    Desai, Akshay S.
    Vaduganathan, Muthiah
    Gasparyan, Samvel B.
    Bengtsson, Olof
    Lindholm, Daniel
    Petersson, Magnus
    Langkilde, Anna Maria
    de Boer, Rudolf A.
    DeMets, David
    Hernandez, Adrian F.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    Kober, Lars
    Lam, Carolyn S. P.
    Martinez, Felipe A.
    Sabatine, Marc S.
    Shah, Sanjiv J.
    Solomon, Scott D.
    McMurray, John J. V.
    NATURE MEDICINE, 2022, 28 (09) : 1956 - +
  • [42] Evaluating the key predictors of health-related quality of life in patients with heart failure and reduced ejection fraction: results from the DAPA-HF trial
    McEwan, P.
    McMurray, J. J. V.
    Jhund, P. S.
    Docherty, K. F.
    Qin, L.
    EUROPEAN HEART JOURNAL, 2021, 42 : 908 - 908
  • [43] Sex Differences in Characteristics, Outcomes, and Treatment Response With Dapagliflozin Across the Range of Ejection Fraction in Patients With Heart Failure: Insights From DAPA-HF and DELIVER
    Wang, Xiaowen
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Hegde, Sheila M.
    Pabon, Maria
    Kulac, Ian J.
    Vardeny, Orly
    O'Meara, Eileen
    Zieroth, Shelley
    Katova, Tzvetana
    McGrath, Martina M.
    Pouleur, Anne-Catherine
    Jhund, Pardeep S.
    Desai, Akshay S.
    Inzucchi, Silvio E.
    Kosiborod, Mikhail N.
    de Boer, Rudolf A.
    Kober, Lars
    Sabatine, Marc S.
    Martinez, Felipe A.
    Ponikowski, Piotr
    Shah, Sanjiv J.
    Hernandez, Adrian F.
    Langkilde, Anna Maria
    McMurray, John J., V
    Solomon, Scott D.
    Lam, Carolyn S. P.
    CIRCULATION, 2023, 147 (08) : 624 - 634
  • [44] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [45] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [46] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [47] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [48] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [49] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
    Zannad, Faiez
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Brueckmann, Martina
    Ofstad, Anne Pernille
    Pfarr, Egon
    Jamal, Waheed
    Packer, Milton
    LANCET, 2020, 396 (10254): : 819 - 829
  • [50] Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction: An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials
    Bhatt, Ankeet S.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Kulac, Ian J.
    Anand, Inder S.
    Desai, Akshay S.
    Fang, James C.
    Hernandez, Adrian F.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Sabatine, Marc S.
    Shah, Sanjiv J.
    Vardeny, Orly
    McMurray, John J. V.
    Solomon, Scott D.
    Gaziano, Thomas A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (05):
12345